Vas Narasimhan (@VasNarasimhan) / Twitter
Vas Narasimhan of Novartis: 'We Are Not at All Prepared for a Pandemic' - The New York Times
Novartis CEO Vas Narasimhan: How We Should Think About Drug Discovery | Fortune
Vas Narasimhan: the American trying to reshape Novartis | Financial Times
BSR Conference 2018 | Vasant Narasimhan | Speakers
Vasant Narasimhan - Wikipedia
Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT | Fierce Pharma
The future of Novartis - YouTube
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
Novartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash | Barron's
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
Novartis CEO Continues Shake-Up, Says Will Save More Than $1 Billion Annually | Barron's
Vas Narasimhan (@VasNarasimhan) / Twitter
Novartis - Speaking at #BSR18, our CEO Vas Narasimhan shares how we are working to help more people get access to the medicines they need #AccessinAction | Facebook
Interview: Vas Narasimhan, the 'unboss' of Novartis | Business | The Sunday Times
Novartis working on pan-coronavirus oral treatment, CEO says | Reuters
Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company - YouTube
The 'student' of leadership who seeks to inspire his employees | Financial Times
Novartis CEO Sees 'Better Place' With Covid by Year-End - Bloomberg
Vasant Narasimhan | Novartis
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | Fierce Pharma
How Novartis Is Finding The Path To Be A Digital Winner
Novartis to cut as many as 8,000 jobs under plan to save $1 billion by 2024 | Fortune
CEO Vas Narasimhan tells employees Novartis' deal with Trump lawyer was a mistake he's determined to overcome | Fierce Pharma
